Supports idea of biological pathway connecting hearing care with better cognitive health
This study, published in the September 2026 edition of EClinical Medecine, is the first to identify measurable biological links of hearing loss treatment to improved brain health.
The study examined blood samples from randomly selected seniors that received comprehensive hearing treatment or healthy aging education. Those receiving hearing aids and audiologic care had a significantly slower increase in neuroinflammatory biomarkers.
The study finding could help researchers understand why hearing treatment appears to slow cognitive decline in aging adults. Study participants were part of the landmark 2023 ACHIEVE (Aging and Cognitive Health Evaluation in Elders) clinical trial.
According to the lead study author, James Russel Pike, “this investigation suggests that hearing intervention may reduce the progression of non-specific biomarkers of neuroinflammation among older adults with hearing loss who have multiple risk factors for incident dementia.”
Moreover, Pike writes, “This finding bolsters the role of hearing loss as a modifiable target for dementia prevention.”
On July 15, 2026, the World Health Organization separately published new recommendations that added hearing aids to dementia prevention guidance. According to WHO, the world spends $1.3 trillion annually to treat dementia, and up to 50% of that financial burden falls on families. Hearing treatment may lower that cost to families.
Many studies as far back as 1949 have identified a link between hearing loss and higher risk of dementia and Alzheimer’s Disease. Numerous studies over the years have more recently noted that comprehensive hearing treatment was associated with lower risk of dementia.
Until this new study finding, most researchers believed the reduced risk of dementia from hearing treatment was linked to better socialization, made possible by better hearing. People with untreated hearing loss are more likely to avoid social contact, especially with groups. Social isolation is a well-documented causal factor in dementia onset. But now evidence is starting to point to biological pathways where hearing treatment may lower or slow brain neuro-degeneration directly.
The science is catching up to what practicing clinicians already know. Properly fit and maintained hearing aids in the context of rehabilitative care, is key for long-term benefit and lower risk of developing dementia. Moreover, consumer electronics advertising downplays the role of the hearing professional. But the technology expertise combined with counseling and rehabilitation care of the hearing professional is the ingredient that makes hearing care with hearing aids most beneficial. Seek local independent hearing care providers that are easy to access and offer truly personalized care.
Follow this Hearing Tracker link for more information and links to the studies: ACHIEVE Study Links Hearing Treatment to Slower Rise in Brain-Health Biomarker
Hear well. Bee well.
